NCT01484015
- Conditions
- Adnexal Diseases, Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, +121 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
Clinical trial condition
Marginal Zone Lymphoma
Explore clinical trials studying Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.
114 public trials
41 recruiting studies
Marginal Zone Lymphoma trial results
NCT01239394
- Conditions
- Chronic Disease, Disease Attributes, Follicular Lymphoma, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.
NCT00801281
- Conditions
- Chronic Disease, Disease Attributes, Follicular Lymphoma, +22 more
- Locations
-
- Podkarpacki Oncology Centre Brzozów, Poland
- Voivodeship Hospital, Oncology Ward Elblag, Poland
- Academic Clinical Centre, Hospital of Medical Academy, Clinic of Haematology and Transplantology Gdansk, Poland
- Silesian Medical University, Chair and Clinic of Haematology and Bone Marrow Transplantation Katowice, Poland
NCT01314014
- Conditions
- Burkitt Lymphoma, Burkitt's Lymphoma, Chronic Disease, +34 more
- Locations
-
- Arizona Cancer Center, University of Arizona Tucson, Arizona, United States
- University of Rochester Medical Center Rochester, New York, United States
NCT00453102
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
Active, Not Recruiting
FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role
NCT04333524
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- CHU de Dijon Dijon, France
- Saint Louis Hospital Paris, France
- IUCT Oncopole Toulouse Toulouse, France
- ASO SS. Antonio e Biagio e C. Arrigo Alessandria, AL, Italy
Active, Not Recruiting
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
NCT05100862
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Ucsf Fresno University of California San Francisco Fresno Fresno, California, United States
- Kaiser Permanente Southern California Irvine, California, United States
- Cancer and Blood Specialty Clinic Los Alamitos, California, United States
- Los Angeles Cancer Network Los Angeles, California, United States
Active, Not Recruiting
A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma
NCT04212013
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- George Washington Cancer Center Washington D.C., District of Columbia, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
Active, Not Recruiting
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
NCT06300528
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
- Locations
-
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
Active, Not Recruiting
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
NCT04542824
- Conditions
- Chronic Disease, Diffuse Large B Cell Lymphoma, Disease Attributes, +25 more
- Locations
-
- Tohoku University Hoaspital Sendai, Miyagi, Japan
- Aichi Cancer Center Hospital Aichi, Japan
- NHO Nagoya Medical Center Aichi, Japan
- National Cancer Center Hospital East Chiba, Japan